Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing
UF Innovate | Accelerate graduate Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced its lead candidate for treating concussion successfully completed a study that indicates ONP-002 does not cause cardiotoxicity.
GatorX Advances to Semi-Final Round of XPRIZE Track B Autonomous Wildfire Challenge
Fire Neural Network (FNN) announced that their team, GatorX, is advancing to the semi-final round of the XPRIZE Track B Autonomous Wildfire Challenge. GatorX is a well-rounded partnership between Fire Neural Network, the University of Florida, NVIDIA, SATLANTIS, SwissDrones, Archer Aviation, SWIR Vision Systems, and N5 Sensors.
Access Pediatric Joins ARPA-H Investor Catalyst Hub to Improve Pediatric Specialty Care
Access Pediatric, a virtual-first, pediatric telehealth platform connecting patients with specialty pediatric physicians, is one of the newest members of the ARPA-H... Read More
Camera in Space to Capture the Impossible
Satlantis has been developing a camera to photograph the universe's dark matter -- which, by the way, is invisible.
JPMorgan Upgrades Solid Biosciences Stock, Sees Growth Potential
JPMorgan upgraded Solid Biosciences stock, a biotechnology company that acquired UF startup AavantiBio, from Neutral to Overweight, and increased the price target to $15.00 from the previous $10.00. The firm's decision reflects a positive outlook on the company's prospects, particularly with upcoming developments expected in the fourth quarter.
Dr. Read Hayes of the LPRC Is Recognized as a Global Thought Leader
The Life Safety Alliance (LSA), an organization dedicated to enhancing global life safety and security through partnerships and collaborations, has announced the results of its Top 40 Global Thought Leaders in Security and Life Safety. UF Innovate | Accelerate client Loss Prevention Research Council's Read Hayes is recognized as a global thought leader.
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Beacon Therapeutics, a leading ophthalmic gene therapy company that acquired UF startup AGTC to save and restore the vision of patients with blinding retinal diseases, announced it has raised $170 million in Series B funding.
Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
Oragenics, Inc., a UF Innovate | Accelerate alumnus company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced it has completed a prototype of its automated intranasal device for use in concussed patients who are initially confused, dazed or unconscious in the acute phase of injury.
Solid Biosciences Joins the Russell 3000® Index
Solid Biosciences Inc., a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases that acquired UF startup AavantiBio, announced it has been added to the broad-market Russell 3000® Index as part of the annual reconstitution, effective July 1st, 2024.
Tech Tuesday: Fire Neural Network
In this week’s Tech Tuesday, UF Innovate host Bethany Gaffey speaks with the CEO of Fire Neural Network about how artificial intelligence is helping to prevent the spread of wildfire.
